http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2514345-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56c13ce337340fd50f39562868ca87c2 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
filingDate | 2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952b365a0ecd98ed526523a3b12803b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01159bd8d06504ca5c7cc0edf1413252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f09c6c86e4fd587219334ac31b59b13 |
publicationDate | 2014-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2514345-C1 |
titleOfInvention | Method for prediction of degree of risk of haemorrhagic complications accompanying minimally invasive liver surgeries |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely surgery, and can be used to evaluate and predict a risk of the haemorrhagic complications accompanying minimally invasive liver surgeries. The presence of the following signs (risk predictors) is scored pre- and intraoperatively in each person individually: evident or latent coagulopathy (CP), hepatic fibrosis or cirrhosis (HC), acute hepatic failure and/or evident cholestasis (CS), technical problems of the surgery (TP), a puncture canal diameter exceeding 1.6 mm (CD), multiple instrument passage through a parenchyma (IP), a dangerous location of a mass lesion (DL) and intra- and postoperative restlessness (R). A haemorrhagic complication risk index (HCRI) is calculated by formula HCRI=CP+HC+CS+TP+CD+IP+DL+R; the derived HCRI <4 points stands for a minimum risk; the HCRI falling within the range of 5-12 points shows a moderate risk, and the surgery is preceded by prescribing a haemostatic course; if the HCRI exceeds 12 points, a high risk of the complications is stated. n EFFECT: method enables more effective prediction of the haemorrhagic complications following the minimally invasive liver surgeries that is necessary for specifying further preventative options. n 1 tbl, 2 ex |
priorityDate | 2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.